Vimarsana
Biggest News Aggregation in the World

Page 28 - High Throughput News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from High Throughput. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In High Throughput Today - Breaking & Trending Today

In-vitro Toxicology Testing Market Size Worth $51.1 Billion By 2028: Grand View Research, Inc. - Vimarsana News

In-vitro Toxicology Testing Market Size Worth $51.1 Billion By 2028: Grand View Research, Inc.

/PRNewswire/ -- The global in-vitro toxicology testing market size is expected to reach USD 51.1 billion by 2028, according to a new report by Grand View...

New testing protocol for SARS-CoV-2 can process thousands of samples within 48 hours - Vimarsana News

New testing protocol for SARS-CoV-2 can process thousands of samples within 48 hours

New testing protocol for SARS-CoV-2 can process thousands of samples within 48 hours Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, is published in the journal Nature Communications and could be adapted to many more pathogens. The COVID-19 pandemic has lasted more than a year and continues to impact our lives tremendously. Although some countries have launched speedy vaccination campaigns, many still await large-scale immunization schemes and effective antiviral the...

Global Drug Discovery and Development Solutions Market to be Driven by the Increasing R&D spending and initiatives for rare disease and orphan drugs research in the Forecast Period of 2021-2026 - Vimarsana News

Global Drug Discovery and Development Solutions Market to be Driven by the Increasing R&D spending and initiatives for rare disease and orphan drugs research in the Forecast Period of 2021-2026

Global Drug Discovery and Development Solutions Market to be Driven by the Increasing R&D spending and initiatives for rare disease and orphan drug

Transform your GC and GC-MS results - Vimarsana News

Transform your GC and GC-MS results

To help you achieve your scientific goals, Thermo Fisher Scientific has created its 2021 Chromatography Innovation Series to share innovations and solutions that will address your most complex analytical challenges. This Series has four topics spanning eight months with spotlights on the latest innovations, applications, information and research. To kick off this Series, Thermo Fisher has unveiled the latest GC-MS innovations that will empower you to transform your gas chromatography and gas chromatography-mass spectrometry results. The presentations include ‘The Next Generation Orbitrap M...

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies - Vimarsana News

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.